Candida auris — a New Pathogen of Nosocomial Infections

In recent years, the number of infectious diseases caused by fungi has been progressively increasing, which is a serious clinical problem. The literature review is devoted to Candida auris — a new causative agent of nosocomial fungal infections with multidrug resistance. This pathogen was first described in 2009. As of the beginning of 2021, the documented isolation of Candida auris was noted in 47 countries around the world. This pathogen can persist for a long time on various surfaces in hospitals, is resistant to antifungal drugs and traditional disinfectants, and causes invasive infections accompanied by high mortality. The study of Candida auris is important both for the development of approaches to the diagnosis and treatment of diseases caused by this pathogen, and for predicting the emergence of new pathogens in the future.